Camptosar and disseminated intravascular coagulation Patient Reports February 11, 2012
Camptosar Side Effects Report #5261275-2
Camptosar side effect was reported by a Health Professional from JAPAN on Feb 26, 2007. Female patient was diagnosed with rectal cancer and was treated with Camptosar. After drug was administered, patient experienced the following side effects: diarrhoea, disseminated intravascular coagulation. Camptosar dosage: DAILY DOSE:230MG. Patient recovered.
Camptosar Side Effects Report #5313031-4
Camptosar side effect was reported by a Health Professional from JAPAN on Apr 19, 2007. Female patient, weighting 112.4 lb, was diagnosed with rectal cancer, pain
, nausea
, constipation
and was treated with Camptosar. After drug was administered, patient experienced the following side effects: diarrhoea, disseminated intravascular coagulation. Camptosar dosage: unknown. During the same period patient was treated with OXYCONTIN, PRIMPERAN, BICARBONATE, MAGNESIUM OXIDE, KYTRIL. Patient recovered.Camptosar Side Effects Report #5884422-8
Camptosar side effect was reported by a Physician from JAPAN on Sept 03, 2008. Male patient, 75 years of age, was diagnosed with gastric cancer and was treated with Camptosar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, disseminated intravascular coagulation, hepatitis fulminant, thrombocytopenia. Camptosar dosage: DAILY DOSE:80MG/M2. During the same period patient was treated with TEGAFUR. Patient died on 09/03/2008.
Camptosar Side Effects Report #5110912-1
Camptosar side effect was reported by a Physician from JAPAN on Sept 06, 2006. Female patient, 72 years of age, was diagnosed with gastric cancer and was treated with Camptosar. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood glucose decreased, cardiac arrest
, constipation
, depressed level of consciousness, disseminated intravascular coagulation, leukopenia, malaise, oral intake reduced. Camptosar dosage: 57 MG/M2, INTRAVENOUS. During the same period patient was treated with CISPLATIN. Patient died on 08/27/2006.Camptosar Side Effects Report #5121328-6
Camptosar side effect was reported by a Physician from JAPAN on Sept 21, 2006. Female patient, 72 years of age, was diagnosed with gastric cancer and was treated with Camptosar. After drug was administered, patient experienced the following side effects: anorexia, ascites, blood creatinine increased, blood pressure diastolic decreased, cardiac arrest
, depressed level of consciousness, disseminated intravascular coagulation, haemorrhage subcutaneous, hypoglycaemia. Camptosar dosage: 57 MG/M2, INTRAVENOUS. During the same period patient was treated with CISPLATIN, DOGMATYL, ULCERMIN, TORSEMIDE, FOSMICIN, LASIX. Patient died on 08/27/2006.Camptosar Side Effects Report #5103838-0
Camptosar side effect was reported by a Physician from JAPAN on Aug 29, 2006. Female patient, 50 years of age, was diagnosed with gastric cancer and was treated with Camptosar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation. Camptosar dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died on 08/27/2006.
Camptosar Side Effects Report #4911081-0
Camptosar side effect was reported by a Physician from FRANCE on Jan 27, 2006. Female patient, 53 years of age, was diagnosed with colon cancer metastatic and was treated with Camptosar. After drug was administered, patient experienced the following side effects: asthenia, circulatory collapse, disseminated intravascular coagulation, fibrosis, gastrointestinal disorder, haematoma, platelet count decreased, rectal haemorrhage, shock. Camptosar dosage: 180 MG/M2 (180 MG/M2), INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, FOLIC ACID, AVASTIN. Patient died.
Camptosar Side Effects Report #4929437-9
Camptosar side effect was reported by a Physician from FRANCE on Feb 13, 2006. Female patient, 53 years of age, was diagnosed with colon cancer metastatic and was treated with Camptosar. After drug was administered, patient experienced the following side effects: circulatory collapse, disseminated intravascular coagulation, gastrointestinal disorder, haematoma, haemoglobin decreased, operative haemorrhage, pallor, rectal haemorrhage, shock haemorrhagic. Camptosar dosage: 180 MG/M2 (180 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, FOLIC ACID, AVASTIN, CALCIUM LEVOFOLINATE. Patient died.
Camptosar Side Effects Report #4860758-4
Camptosar side effect was reported by a Physician from JAPAN on Nov 30, 2005. Female patient, 77 years of age, weighting 108.0 lb, was diagnosed with colon cancer and was treated with Camptosar. After drug was administered, patient experienced the following side effects: atrial fibrillation
, bone marrow failure, coagulopathy, depressed level of consciousness, disseminated intravascular coagulation, enterocolitis, epilepsy
, leukopenia, neutrophil count decreased. Camptosar dosage: 100 MG/M2 (100 MG/M2, 1 IN 1 WK), INTRAVENOUS. Patient recovered.
Camptosar and disseminated intravascular coagulation 